Lumbard & Kellner’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-125,744
| Closed | -$1.96M | – | 98 |
|
|
2022
Q4 | $1.96M | Sell |
125,744
-1,202
| -0.9% | -$18.8K | 0.96% | 37 |
|
|
2022
Q3 | $1.65M | Sell |
126,946
-2,651
| -2% | -$34.4K | 0.85% | 40 |
|
|
2022
Q2 | $1.82M | Sell |
129,597
-2,919
| -2% | -$41K | 0.93% | 41 |
|
|
2022
Q1 | $1.9M | Hold |
132,516
| – | – | 0.74% | 43 |
|
|
2021
Q4 | $1.92M | Sell |
132,516
-4,177
| -3% | -$60.4K | 0.72% | 44 |
|
|
2021
Q3 | $2.24M | Sell |
136,693
-1,056
| -0.8% | -$17.3K | 0.88% | 40 |
|
|
2021
Q2 | $2.32M | Buy |
137,749
+2,199
| +2% | +$37K | 0.9% | 35 |
|
|
2021
Q1 | $2.26M | Sell |
135,550
-828
| -0.6% | -$13.8K | 0.8% | 37 |
|
|
2020
Q4 | $2.4M | Sell |
136,378
-1,052
| -0.8% | -$18.5K | 0.95% | 36 |
|
|
2020
Q3 | $2.12M | Buy |
137,430
+14,645
| +12% | +$225K | 1.04% | 34 |
|
|
2020
Q2 | $2.2M | Sell |
122,785
-5,636
| -4% | -$101K | 1.27% | 31 |
|
|
2020
Q1 | $1.95M | Sell |
128,421
-4,981
| -4% | -$75.6K | 1.31% | 30 |
|
|
2019
Q4 | $2.63M | Sell |
133,402
-402
| -0.3% | -$7.93K | 1.36% | 28 |
|
|
2019
Q3 | $2.3M | Hold |
133,804
| – | – | 1.26% | 29 |
|
|
2019
Q2 | $2.37M | Sell |
133,804
-176
| -0.1% | -$3.12K | 1.27% | 27 |
|
|
2019
Q1 | $2.73M | Buy |
+133,980
| New | +$2.73M | 1.52% | 23 |
|